While the prothrombotic significance of MTHFR mutations and elevated homocysteine remains controversial, EBV-induced inflammation may have exacerbated their thrombogenic potential, particularly in the absence of other thrombophilias. The gene discussed is MTHFR; the disease is thrombophilia.